Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics
The DOI matches its Crossref record; 148 of the 149 references it cites were found in a registry or an index.
Abstract
Difficulties initiating or maintaining sleep are frequently encountered in patients with schizophrenia. Disturbed sleep can be found in 30-80% of schizophrenic patients, depending on the degree of psychotic symptomatology. Measured by polysomnography, reduced sleep efficiency and total sleep time, as well as increased sleep latency, are found in most patients with schizophrenia and appear to be an important part of the pathophysiology of this disorder. Some studies also reported alterations of stage 2 sleep, slow-wave sleep (SWS) and rapid eye movement (REM) sleep variables, i.e. reduced REM latency and REM density. A number of sleep parameters, such as the amount of SWS and the REM latency, are significantly correlated to clinical variables, including severity of illness, positive symptoms, negative symptoms, outcome, neurocognitive impairment and brain structure.Concerning specific sleep disorders, there is some evidence that schizophrenic patients carry a higher risk of experiencing a sleep-related breathing disorder, especially those demonstrating the known risk factors, including being overweight but also long-term use of antipsychotics. However, it is still unclear whether periodic leg movements in sleep or restless legs syndrome (RLS) are found with a higher or lower prevalence in schizophrenic patients than in healthy controls.There are no consistent effects of first-generation antipsychotics on measures of sleep continuity and sleep structure, including the percentage of sleep stages or sleep and REM latency in healthy controls. In contrast to first-generation antipsychotics, the studied atypical antipsychotics (clozapine, olanzapine, quetiapine, risperidone, ziprasidone and paliperidone) demonstrate a relatively consistent effect on measures of sleep continuity, with an increase in either total sleep time (TST) or sleep efficiency, and individually varying effects on other sleep parameters, such as an increase in REM latency observed for olanzapine, quetiapine and ziprasidone, and an increase in SWS documented for olanzapine and ziprasidone in healthy subjects.The treatment of schizophrenic patients with first-generation antipsychotics is consistently associated with an increase in TST and sleep efficiency, and mostly an increase in REM latency, whereas the influence on specific sleep stages is more variable. On the other hand, withdrawal of such treatment is followed by a change in sleep structure mainly in the opposite direction, indicating a deterioration of sleep quality. On the background of the rather inconsistent effects of first-generation antipsychotics observed in healthy subjects, it appears possible that the high-potency drugs exert their effects on sleep in schizophrenic patients, for the most part, in an indirect way by suppressing stressful psychotic symptomatology. In contrast, the available data concerning second-generation antipsychotics (clozapine, olanzapine, risperidone and paliperidone) demonstrate a relatively consistent effect on measures of sleep continuity in patients and healthy subjects, with an increase in TST and sleep efficiency or a decrease in wakefulness. Additionally, clozapine and olanzapine demonstrate comparable influences on other sleep variables, such as SWS or REM density, in controls and schizophrenic patients. Possibly, the effects of second-generation antipsychotics observed on sleep in healthy subjects and schizophrenic patients might involve the action of these drugs on symptomatology, such as depression, cognitive impairment, and negative and positive symptoms.Specific sleep disorders, such as RLS, sleep-related breathing disorders, night-eating syndrome, somnambulism and rhythm disorders have been described as possible adverse effects of antipsychotics and should be considered in the differential diagnosis of disturbed or unrestful sleep in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in this context it is difficult to associate any changes reported in sleep variables directly to changes in symptoms due to the likely direct of antipsychotic medication on sleep via their influence on multiple neurotransmitter systems (Cohrs, 2008).”
From The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review (2015) · cites this paper as Cohrs, 2008
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Regularly Occurring Periods of Eye Motility, and Concomitant Phenomena, During Sleep
Aserinsky, E., & Kleitman, N. (1953) · Science · doi:10.1126/science.118.3062.273 · Cited by 2,475
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Sleep and Psychiatric Disorders: A Meta-analysis
Benca, R. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080059010 · Cited by 1,468
Strollo, P. J., & Rogers, R. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340207 · Cited by 1,313
Doi, Y., Minowa, M., Uchiyama, M., Okawa, M., Kim, K., Shibui, K., & Kamei, Y. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00232-8 · Cited by 992
Ekbom, K. A. (1960) · Neurology · doi:10.1212/wnl.10.9.868 · Cited by 841
Research works printed but not linked: 13
- Donlon, 1975, Dis Nerv Syst Jun, 36, 323
- Royuela, 2002, Neurobiol Sleep Wakefulness Cycle, 2, 37
- Navarro, 1998, Psicologia Conductal, 6, 49
- Keshavan, 1990, Sleep Res, 19, 330
- Overall, 1962, Psychol Rep, 10, 779
- Rotenberg, 1997, Homeostasis, 38, 97
- Benson, 1994, Am Psychiatr Assoc Rev Psychiatry, 13, 677
- Neeper, 1992, Sleep Res, 21, 154
- Gillin, 1977, Commun Psychopharmacol, 1, 225
- Toyoda, 1964, Folia Psychiatr Neurol Jpn, 18, 198
- Cohrs, 2004, Psychopharmacol (Berl), 174, 421
- Ruther, 1976, Arzneimittelforschung, 26, 1071
- Huapaya, 1976, Am J Psychiatry, 133, 1207
Cited by
European guideline for the diagnosis and treatment of insomnia
Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., Espie, C. A., Garcia‐Borreguero, D., Gjerstad, M., Gonçalves, M., et al. (2017) · Journal of Sleep Research · doi:10.1111/jsr.12594 · Cited by 2,049
“Monti and Monti (2004; Monti et al., 2017) and Cohrs (2008) concluded that sedating antipsychotics increase total sleep time and the amount of slow-wave sleep in patients with schizophrenia.”
Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease
Wulff, K., Gatti, S., Wettstein, J. G., & Foster, R. G. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2868 · Cited by 1,055
“Abnormal sleep patterns in schizophrenia include reductions in REM latency, REM density, sleep efficiency, total sleep time and the duration of NREM stage 4, and an increase in sleep latenc”
BackgroundMorin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Sleep, insomnia, and depression
Riemann, D., Krone, L. B., Wulff, K., & Nissen, C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 819
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
“contribute to the risk of sleep disturbances or may, in fact, help to reverse them.(241) Overall, no definitive evidence is”
Metadata
- Authors
- Cohrs, S.
- Affiliations
- University of Göttingen (DE)
- Corresponding author
- Cohrs, Stefan
- Venue
- CNS Drugs
- Published
- 2008
- Volume
- 22
- Issue
- 11
- Pages
- 939-962
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W2183656574
- Cited by
- 433
- References
- 149
- Citations by year
- 2026: 19 · 2025: 19 · 2024: 23 · 2023: 24 · 2022: 29 · 2021: 25 · 2020: 29 · 2019: 27 · 2018: 24 · 2017: 35 · 2016: 37 · 2015: 31 · 2014: 16 · 2013: 32 · 2012: 20
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- schizophrenia, sleep disorders, sleep efficiency, sleep latency, REM sleep, slow-wave sleep, REM latency, atypical antipsychotics, typical antipsychotics, sleep-disordered breathing, periodic limb movements in sleep, restless legs syndrome, antipsychotic withdrawal, sleep quality, polysomnography, neurocognitive impairment, positive and negative symptoms
- MeSH terms
- Humans, Schizophrenia, Sleep, Sleep Wake Disorders, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics. https://app.cochat.ai/papers/10.2165/00023210-200822110-00004
- The paper
- Cohrs, S. (2008). Sleep Disturbances in Patients with Schizophrenia: Impact and Effect of Antipsychotics. CNS Drugs. https://doi.org/10.2165/00023210-200822110-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.